logo
Plus   Neg
Share
Email

Merck Gets FDA Approval Of Prevymis For Prevention Of CMV Infection

Merck & Co., Inc. (MRK), known as MSD outside the United States and Canada, said that the U.S. Food and Drug Administration has approved Prevymis or letermovir once-daily tablets for oral use and injection for intravenous infusion.

Prevymis is indicated for prophylaxis or prevention of cytomegalovirus or CMV infection and disease in adult CMV-seropositive recipients of an allogeneic hematopoietic stem cell transplant (HSCT).

CMV is a common and potentially serious viral infection in allogeneic HSCT recipients. CMV-seropositive patients who undergo an HSCT are at high risk for CMV reactivation. Any level of CMV infection is associated with increased mortality in HSCT patients.

In the pivotal Phase 3 clinical trial supporting approval, significantly fewer patients in the Prevymis group, or 38 percent, compared to the placebo group or 61 percent, developed clinically significant CMV infection, discontinued treatment or had missing data through Week 24 post-HSCT, the primary efficacy endpoint.

Prevymis is expected to be available in December. The list price per day for Prevymis tablets is $195.00 and for Prevymis injection is $270.00. Wholesaler acquisition costs do not include discounts that may be paid on the product.

by RTTNews Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
Nike Inc. (NKE), the world's largest athletic shoes and apparel maker, Tuesday reported a first-quarter profit that increased from a year ago and trumped Wall Street estimates, driven largely by more-than-expected revenues and strong margins. Beaverton, Oregon-based Nike's first-quarter profit rose... German auto giant BMW (BMW.L, BAMXF.PK, BAMXY.PK) Tuesday lowered its earnings and revenue guidance for the full year 2018, hurt largely by emissions-related costs, product recalls and ongoing global trade war. Automotive segment revenues are now expected to be slightly lower than the previous year.... Walt Disney World is introducing a new ticket pricing system in order to better distribute attendance at its theme parks throughout the year. The company plans to begin pricing tickets for its theme parks based on dates so as to reflect the expected demand on specific days. Disney said Monday that beginning October 16, guests will be able to access its new online vacation-booking portal.
Follow RTT